Comparative study on ATG-thymoglobulin versus ATG-fresenius for the graft-versus-host disease (GVHD) prophylaxis in allogeneic stem cell transplantation from matched unrelated donor: a single-centre experience over the contemporary years-Reference-Cited by-同舟云学术

Comparative study on ATG-thymoglobulin versus ATG-fresenius for the graft-versus-host disease (GVHD) prophylaxis in allogeneic stem cell transplantation from matched unrelated donor: a single-centre experience over the contemporary years

Published:2018-03-12 Issue:11 Volume:59 Page:2700-2705
ISSN:1042-8194
Container-title:Leukemia & Lymphoma
language:en
Short-container-title:Leukemia & Lymphoma

Author:

Polverelli Nicola¹,Malagola Michele¹,Turra Alessandro¹,Skert Cristina¹,Perucca Simone¹²,Chiarini Marco³,Cattina Federica¹,Rambaldi Benedetta¹,Cancelli Valeria¹,Morello Enrico¹,Schieppati Francesca¹,Bernardi Simona¹²,Zanaglio Camilla¹²,Sottini Alessandra²,Giustini Viviana²,Imberti Luisa²,Montanelli Alessandro³,Russo Domenico¹

Affiliation:

1. Unit of Blood Diseases and Stem Cells Transplantation, Department of Clinical and Experimental Sciences, University of Brescia, ASST Spedali Civili of Brescia, Brescia, Italy;

2. Laboratorio CREA (Centro di Ricerca Emato-oncologica AIL), ASST Spedali Civili of Brescia, Brescia, Italy;

3. Clinical Chemistry Laboratory, Department of Diagnostics, ASST Spedali Civili of Brescia, Brescia, Italy

Publisher

Informa UK Limited

Subject

Cancer Research,Oncology,Hematology

Link

https://www.tandfonline.com/doi/pdf/10.1080/10428194.2018.1439584

Reference15 articles.

1. CLINICAL MANIFESTATIONS OF GRAFT-VERSUS-HOST DISEASE IN HUMAN RECIPIENTS OF MARROW FROM HL-A-MATCHED SIBLING DONOR,S

2. National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: I. Diagnosis and Staging Working Group Report

3. Prophylaxis and treatment of GVHD: EBMT–ELN working group recommendations for a standardized practice